Japan prazosin market is estimated to decline at a CAGR of around -2.6% during the forecast period. Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Minipress in Japan and is used for the treatment of various diseases including BPH, heart failure, high blood pressure, and Raynaud’s syndrome. According to the American Heart Association in 2018, 43 million people in Japan were hypertensive, of which only 50% are treated, and about 25% are controlled at the target blood pressure (BP) level of <140/90 mm?Hg. The large number of hypertensive populations coupled with its poor control rate; hypertension is one of the leading causes of mortality in the country. In addition, in July 2019, the two companies announced a definitive agreement for combining Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical company.
Get Free Sample link @ https://www.omrglobal.com/request-sample/japan-prazosin-market
Japan prazosin market is segmented on the basis of application. Based on the application, the market is segmented into cardiovascular disease, neurological syndromes, prostate disorders, and kidney disorders. The CVD segment accounted for a significant share in the Japan prazosin market. CVDs claim to take more lives each year than all forms of cancer and chronic lower respiratory diseases altogether. Thus, prazosin is one of the treatments used for CVD mainly high BP and strokes. For instance, Minipress is specified for the treatment of hypertension, to control BP. Lowering blood pressure decreases the risk of fatal and nonfatal cardiovascular events, mainly strokes and myocardial infarction.
A full report of Japan Prazosin Market available @ https://www.omrglobal.com/industry-reports/japan-prazosin-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Japan Prazosin Market by Application
- Cardiovascular Disease( CVD)
- Neurological Syndromes
- Prostate Disorders
- Kidney Disorders
Company Profiles
- Ajinomoto Co., Inc.
- Johnlee Pharmaceuticals Pvt. Ltd.
- Merck KGaA
- Pfizer Inc.
- R&D Systems Inc.
- Renata Ltd.
- Mylan N.V.
- Standard Chem and Pharmaceuticals Co. Ltd.
- Sun Pharmaceuticals Industries Ltd.
- Teva Pharmaceuticals Industries Ltd.
The Report Covers
- Comprehensive research methodology of the Japan prazosin market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Japan prazosin market.
- Insights about market determinants which are stimulating the Japan prazosin market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/japan-prazosin-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
